InterCare DX, Inc. (ICCO) 股票表現
查看InterCare DX, Inc.的財務表現,包括市值、價格變動百分比、本益比,以及歷史和當前股價。
前收盤價0.00
52週高點0.00
打開0.00
52週低點0.00
資金流向0.00%
本益比0%
T/O0.00b
市淨率0%
離職率0.00%
市值0.00b
股息0
總股數0.74b
股息殖利率0%
批量大小1
InterCare DX, Inc.公司簡介
InterCare Dx, Inc., is a USFDA registered biomedical and life sciences company with main office located at 20300 South Vermont Avenue, Suite 215, Torrance, California, USA, and international partners located worldwide.We have also developed an Integrated, web-enabled applications target towards (a) Education Management, (b) Hospitality Management,(c) Legal System Management,(d) Human Capital Management and (e) Healthcare Management industry markets. In addition, we designed, developed and commercialized the "The Mirage Systems Biofeedback and Self Regulation Software Program", the first USFDA approved Software only biofeedback program for clinical use. This product was licensed to United States Navy Submarine division in San Diego California in 1995 and a research center in Germany We have also Commercialized "Vascular Diagnostic Center (Vasocor Model 300)", a freestanding diagnostic device that employs a revolutionary non-invasive, inexpensive, easy-to- use procedure that has been clinically proven to detect coronary artery disease ("CAD") earlier and more accurately than existing techniques. Users include primary care physicians, cardiologists, vascular specialists, clinics, and hospitals. The device is simple enough to be operated by non-physicians and non-nurses. Further, the Vasocor device has FDA approval, validated clinical trial data and qualified for Medicare reimbursement.